Life science advertising follows different rules from advertising for consumer products. The audience is more technical, the claims are regulated, and the people you want to reach rarely respond to the tactics that work for shoes, apps or restaurants. Companies that copy a standard advertising playbook usually end up with plenty of clicks and very few qualified conversations.
Here is where life science advertising really diverges, and what to do about it.
1. Your audience is small, expert and skeptical
A consumer brand might target millions of people. A biotech or medtech company often needs to reach a few hundred: researchers, clinicians, procurement leads, investors and partnership teams. These people read data for a living, and they notice vague claims immediately.
That changes how you write and where you spend. Broad awareness campaigns waste budget. Precise targeting by job title, institution type and research focus does far more, because every impression lands closer to a real decision maker.
2. Regulation shapes what you can say
Many life science products, especially those that touch patient care, sit under strict promotional rules. In the United States, the FDA’s prescription drug advertising guidance sets expectations for how products can be promoted. Other regions have their own codes of practice, and platforms such as Google and LinkedIn apply additional restrictions to healthcare advertising.
In practice this means claims must be accurate, balanced and supportable. Marketers need to work closely with regulatory and scientific teams, and every headline needs a source behind it. This slows things down compared with regular advertising, but it also protects your credibility. If you are unsure what applies to your product, check with your regulatory advisers before a campaign goes live.
3. The sales cycle is long and involves many people
Nobody buys a research platform or a diagnostic tool on impulse. A single purchase may involve a scientist who finds you, a lab manager who evaluates you, a procurement team that approves you and a director who signs off. Each person asks different questions.
So your advertising has to support a journey, not a single click. Early ads introduce the problem you solve. Later content, such as application notes, case studies and comparison data, helps each stakeholder justify the decision internally. Measuring success by immediate sales alone will make good campaigns look like failures.
4. Trust matters more than persuasion
Regular advertising often relies on urgency, emotion and bold promises. In life science, that approach backfires. Scientific buyers trust evidence, transparency and consistency, so the strongest campaigns lead with data, publications, validation and clear explanations of how the technology works.
This is also why your website matters so much. When an ad earns a visit, the page has seconds to show visitors what you do and who it is for. Our article on why biotech websites fail the 5-second test explains how to avoid losing the visitors your advertising paid to attract.
5. The message has to be translated, not simplified
Complex science is hard to explain, and the temptation is either to bury visitors in jargon or to oversimplify until the message loses meaning. The better approach is translation: keep the substance, but state the benefit and the problem it solves in plain language first, then offer the technical depth for those who want it.
Clear messaging is the base of every successful campaign. If you want help sharpening yours, see our life science marketing services.
6. Success is measured by quality, not volume
A regular advertiser might celebrate a million impressions. A life science company should care about a handful of the right conversations: a researcher requesting a demo, a distributor asking about partnership, an investor reading the technology page. Track qualified enquiries, meeting requests and downloads of technical material, not just traffic. Google’s guidance on creating helpful, people-first content is a useful reminder that real usefulness drives results over time.
Key takeaways
- Target narrowly. The right few hundred people matter more than millions of impressions.
- Build compliance and scientific review into your process from the start.
- Plan for a long, multi-person decision, and create content for each stage.
- Lead with evidence and plain language, not hype.
- Measure qualified conversations, not vanity metrics.
Ready to reach the right audience?
At Biond Marketing, we help biotech, medtech and life science companies turn complex technology into clear messaging and campaigns that reach the people who matter. Get in touch to talk through what would work for your company, or explore more guides on our marketing blog.
